Hunter Shkolnik Comments on Proposed Opioid Settlement
December 5, 2019
Source: Daily Stock Dish
Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review of pricing data and industry analysts.
The deal is “overvalued to make the settlement look better,” said Hunter Shkolnik, a lawyer on the plaintiffs executive committee that is managing more than 2,300 federal lawsuits consolidated in the U.S. District Court in Cleveland.
“I don’t believe a no-cash payment from Teva, one of the largest generic manufacturers in the world, is appropriate,” he told Reuters.
Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors, AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp.
Download
Featured Attorneys
Related Articles
Transvaginal Mesh Complications
May 6, 2016
It is not surprising to anyone that both age and childbirth individually and in combination take their tolls on the human body. Many medical complications result from both. One of the more common medical complication from both or either that women suffer from are stress urinary incontinence as well as pelvic organ prolapse. Surgeons and…Read the article
Colton Haynes & Dylan McDermott Share Addiction Stories
August 31, 2019
The former Arrow regular is just starting the road to sobriety, and the veteran actor has successfully stayed on that path for thirty-five years. In 2018, a combination of “depression, anxiety, alcoholism, & addiction” forced Haynes into a California hospital. Yet he describes his recovery as “the most beautiful struggle I’ve ever had to go…Read the article